MTOR and colorectal carcinoma: In CRC, genetic alterations in PIK3CA and PTEN genes lead to sustained activation of the PI3K/AKT/mTOR pathway, promoting cell survival, proliferation, angiogenesis, and resistance to apoptosis [360].